EQNR vs INVX

Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.

INVX exhibits strong balance sheet health with a Piotroski F-Score of 7/9 and an exceptionally low debt-to-equity ratio of 0.07. However, the stock is fundamentally overvalued, trading at $28.15 despite a Graham Number of $20.33 and a growth-based intrinsic value of $8.40. This valuation disconnect is exacerbated by a severe collapse in year-over-year earnings growth (-56.8%) and aggressive insider selling totaling over $326 million. While the 1-year price performance is strong, the combination of bearish technicals and massive insider exits suggests the stock is currently priced for perfection in a deteriorating earnings environment.